119 related articles for article (PubMed ID: 27140038)
21. Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial.
Alam M; Hughart R; Geisler A; Paghdal K; Maisel A; Weil A; West DP; Veledar E; Poon E
JAMA Dermatol; 2018 Jul; 154(7):765-772. PubMed ID: 29710212
[TBL] [Abstract][Full Text] [Related]
22. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement.
Brody HJ
Dermatol Surg; 2005 Aug; 31(8 Pt 1):893-7. PubMed ID: 16042932
[TBL] [Abstract][Full Text] [Related]
23. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.
Kim DW; Yoon ES; Ji YH; Park SH; Lee BI; Dhong ES
J Plast Reconstr Aesthet Surg; 2011 Dec; 64(12):1590-5. PubMed ID: 21807574
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.
Wang M; Li W; Zhang Y; Tian W; Wang H
Dermatol Surg; 2017 Feb; 43(2):246-254. PubMed ID: 27930375
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
Hirsch RJ; Brody HJ; Carruthers JD
J Cosmet Laser Ther; 2007 Sep; 9(3):182-5. PubMed ID: 17763028
[TBL] [Abstract][Full Text] [Related]
26. Commentary on: Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
DeLorenzi C
Aesthet Surg J; 2020 Feb; 40(3):327-329. PubMed ID: 31942932
[No Abstract] [Full Text] [Related]
27. Low dose of Hyaluronidase to treat over correction by HA filler--a case report.
Menon H; Thomas M; D'silva J
J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):e416-7. PubMed ID: 20133216
[No Abstract] [Full Text] [Related]
28. Intra-Arterial Thrombolytic Therapy Is Not a Therapeutic Option for Filler-Related Central Retinal Artery Occlusion.
Chen YC; Wu HM; Chen SJ; Lee HJ; Lirng JF; Lin CJ; Chang FC; Luo CB; Guo WY
Facial Plast Surg; 2018 Jun; 34(3):325-329. PubMed ID: 29378380
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronidase: Understanding Its Properties and Clinical Application for Cosmetic Injection Adverse Events.
Harrison J; Rhodes O
Plast Surg Nurs; 2017; 37(3):109-111. PubMed ID: 28858168
[TBL] [Abstract][Full Text] [Related]
30. [The hyaluronic acid-hyaluronidase system; clinical use of hyaluronidase in infusions].
BOYENS H
Ther Ggw; 1950 Jun; 89(6):169-77. PubMed ID: 15442987
[No Abstract] [Full Text] [Related]
31. Update on Emergency and Nonemergency Use of Hyaluronidase in Aesthetic Dermatology.
Jones DH
JAMA Dermatol; 2018 Jul; 154(7):763-764. PubMed ID: 29710242
[No Abstract] [Full Text] [Related]
32. Streptococcal-hyaluronidase. V. The effect of penicillin on the production of hyaluronic acid and hyaluronidase by hemolytic streptococci (type 28, group A).
ROSENDAL K; FABER V
Acta Pathol Microbiol Scand; 1955; 37(3):293-9. PubMed ID: 13258240
[No Abstract] [Full Text] [Related]
33. Streptococcal-hyaluronidase. IV. The effect of penicillin on the production of hyaluronic acid and hyaluronidase by hemolytic streptococci (type 4, group A).
FABER V; ROSENDAL K
Acta Pathol Microbiol Scand; 1955; 37(3):286-92. PubMed ID: 13258239
[No Abstract] [Full Text] [Related]
34. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronidase Caveats in Treating Filler Complications.
Landau M
Dermatol Surg; 2015 Dec; 41 Suppl 1():S347-53. PubMed ID: 26618463
[TBL] [Abstract][Full Text] [Related]
36. Erasing restylane.
Soparkar CN; Patrinely JR; Tschen J
Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):317-8. PubMed ID: 15266148
[TBL] [Abstract][Full Text] [Related]
37. Clinical Outcomes of Impending Nasal Skin Necrosis Related to Nose and Nasolabial Fold Augmentation with Hyaluronic Acid Fillers.
Sun ZS; Zhu GZ; Wang HB; Xu X; Cai B; Zeng L; Yang JQ; Luo SK
Plast Reconstr Surg; 2015 Oct; 136(4):434e-441e. PubMed ID: 26397262
[TBL] [Abstract][Full Text] [Related]
38. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.
Hirsch RJ; Cohen JL; Carruthers JD
Dermatol Surg; 2007 Mar; 33(3):357-60. PubMed ID: 17338697
[No Abstract] [Full Text] [Related]
39. Hyaluronic acid-hyaluronidase and the rheumatic diseases.
REGAN C; MEYER K
Ann N Y Acad Sci; 1950 May; 52(7):1108-11. PubMed ID: 15426133
[No Abstract] [Full Text] [Related]
40. [Hyaluronidase and hyaluronic acid in some signs of infection and immunity. VI. Effect of hyaluronidase and hyaluronic acid on the reactivity to a tetravaccine and preventive properties of immune sera].
ALAVERDIAN ML
Biull Eksp Biol Med; 1962 Jan; 53():81-5. PubMed ID: 13860022
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
